Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain

Pain

Volumn 97, Issue 3, 2002, Pages 267-273

  Smith, Lesley J ^a   Shih, Andre ^a   Miletic, Gordana ^a   Miletic, Vjekoslav ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chronic constriction injury; Local anesthetic; Osmotic pump; Sciatic nerve; Thermal hyperalgesia

Indexed keywords

LIDOCAINE;

ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; HYPERALGESIA; LATENT PERIOD; MALE; NERVE LIGATION; NONHUMAN; OSMOTIC MINIPUMP; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANESTHETICS, LOCAL; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INFUSION PUMPS, IMPLANTABLE; LIDOCAINE; LIGATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SCIATICA;

EID: 0036285073     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00028-3     Document Type: Article

References (46)

1. The anti-allodynic effects of amytriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
2. New analgesics for neuropathic pain: The lidocaine patch
3. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy
4. Xylocaine for the relief of postoperative pain
5. An animal model of neuropathic pain: A review
6. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
7. Analgesic responses to I.V. lidocaine
8. Subcutaneous lidocaine for treatment of neuropathic cancer pain
9. Anti-arrhythmic effects of lidocaine metabolites
10. Molecular mechanisms of local anesthesia: A review
11. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas
12. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats
13. Peripheral and central hyperexcitability: Differential signs and symptoms in persistent pain
14. Topical lidocaine patch relieves a variety of neuropathic pain conditions: An open-label study
15. Neuropathic pain and injured nerve: Peripheral mechanisms
16. Systemic lidocaine silences ectopic neuroma and DRG discharges without blocking nerve conduction
17. + channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation
18. NaN, a novel voltage-gated Na channel is expressed preferentially in the peripheral sensory neurons and down-regulated after axotomy
19. The effects of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers
20. Changes in post-tetanic potentiation of A-fiber dorsal horn field potentials parallel the development and disappearance of neuropathic pain after sciatic nerve ligation in rats
21. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation
22. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain
23. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
24. Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction
25. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy
26. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat
27. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy
28. Simultaneous quantitation of lidocaine and its four metabolites by high-performance liquid chromatography: Application to studies on in vitro and in vivo metabolism of lidocaine in rats
29. Preemptive analgesia
30. Low-dose-lidocaine reduces secondary hyperalgesia by a central mode of action
31. Systemic lidocaine for neuropathic pain relief
32. Lidocaine test in neuralgia
33. Lignocaine selectively reduced C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin implications for the development of novel centrally acting analgesics
34. QX-314 inhibits ectopic nerve activity associated with neuropathic pain
35. Spinal and supraspinal mechanisms of neuropathic pain
36. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain
37. Both intravenous lidocaine and morphine reduced the pain of postherpetic neuralgia
38. Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat
39. Protracted relief of experimental neuropathic pain by systemic local anesthetics: How, where and when?
40. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: Effects of chronic constrictive injury, transection, and strychine
41. Clinical features and differential diagnosis of peripheral neuropathy
42. Properties of afferent nerve impulses originating from a neuroma
43. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain
44. Sodium channels and pain
45. Transcriptional and posttranslational plasticity and the generation of inflammatory pain
46. Ethical guidelines for investigations of experimental pain in conscious animals